| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update JS Smolen, R Landewé, FC Breedveld, M Buch, G Burmester, ... Annals of the rheumatic diseases 73 (3), 492-509, 2014 | 6333* | 2014 |
| Classification criteria for Sjögren’s syndrome C Vitali, N Del Papa Sjögren's Syndrome, 47-60, 2016 | 5372 | 2016 |
| Genetics of rheumatoid arthritis contributes to biology and drug discovery Y Okada, D Wu, G Trynka, T Raj, C Terao, K Ikari, Y Kochi, K Ohmura, ... Nature 506 (7488), 376-381, 2014 | 1595 | 2014 |
| Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection O Hermine, F Lefrère, JP Bronowicki, X Mariette, K Jondeau, ... New England Journal of Medicine 347 (2), 89-94, 2002 | 895 | 2002 |
| 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: a consensus and data-driven methodology … CH Shiboski, SC Shiboski, R Seror, LA Criswell, M Labetoulle, ... Annals of the rheumatic diseases 76 (1), 9-16, 2017 | 891 | 2017 |
| Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective … F Tubach, D Salmon, P Ravaud, Y Allanore, P Goupille, M Bréban, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 667 | 2009 |
| High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized … JP Fermand, P Ravaud, S Chevret, M Divine, V Leblond, C Belanger, ... Blood, The Journal of the American Society of Hematology 92 (9), 3131-3136, 1998 | 658 | 1998 |
| EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome R Seror, P Ravaud, SJ Bowman, G Baron, A Tzioufas, E Theander, ... Annals of the rheumatic diseases 69 (6), 1103-1109, 2010 | 651 | 2010 |
| The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren’s syndrome X Mariette, S Roux, J Zhang, D Bengoufa, F Lavie, T Zhou, R Kimberly Annals of the rheumatic diseases 62 (2), 168-171, 2003 | 618 | 2003 |
| Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates K Fizazi, A Lipton, X Mariette, JJ Body, Y Rahim, JR Gralow, G Gao, L Wu, ... Journal of Clinical Oncology 27 (10), 1564-1571, 2009 | 573 | 2009 |
| Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren’s syndrome JE Gottenberg, N Cagnard, C Lucchesi, F Letourneur, S Mistou, T Lazure, ... Proceedings of the National Academy of Sciences 103 (8), 2770-2775, 2006 | 566 | 2006 |
| Treat-to-target in systemic lupus erythematosus: recommendations from an international task force RF Van Vollenhoven, M Mosca, G Bertsias, D Isenberg, A Kuhn, ... Annals of the rheumatic diseases 73 (6), 958-967, 2014 | 479 | 2014 |
| Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases JE Gottenberg, L Guillevin, O Lambotte, B Combe, Y Allanore, ... Annals of the rheumatic diseases 64 (6), 913-920, 2005 | 469 | 2005 |
| Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS) X Mariette, P Ravaud, S Steinfeld, G Baron, J Goetz, E Hachulla, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 454 | 2004 |
| Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France X Mariette, D Cazals-Hatem, J Warszawki, F Liote, N Balandraud, J Sibilia Blood 99 (11), 3909-3915, 2002 | 449 | 2002 |
| A phase I study of AMGN‐0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases JJ Body, P Greipp, RE Coleman, T Facon, F Geurs, JP Fermand, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2003 | 436 | 2003 |
| 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus M Aringer, K Costenbader, D Daikh, R Brinks, M Mosca, ... Arthritis & rheumatology 71 (9), 1400-1412, 2019 | 435 | 2019 |
| High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized … JP Fermand, S Katsahian, M Divine, V Leblond, F Dreyfus, M Macro, ... Journal of clinical oncology 23 (36), 9227-9233, 2005 | 407 | 2005 |
| Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis MH Buch, JS Smolen, N Betteridge, FC Breedveld, G Burmester, T Dörner, ... Annals of the rheumatic diseases 70 (6), 909-920, 2011 | 389 | 2011 |
| Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey M De Bandt, J Sibilia, X Le Loët, S Prouzeau, B Fautrel, C Marcelli, ... Arthritis research & therapy 7 (3), 1-7, 2005 | 385 | 2005 |
